News & Updates
Showing Multidisciplinary articles
Showing
2-year data support nerve-sparing technique in prostate cancer surgery
An updated 24-month analysis of the NeuroSAFE PROOF study continues to support robot-assisted radical prostatectomy (RARP) guided by the nerve-sparing NeuroSAFE technique in men with prostate cancer.
2-year data support nerve-sparing technique in prostate cancer surgery
27 Mar 2026
CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition
In an observational study of two community-based cohorts in Hong Kong, 6.7 percent of individuals with BMI ≥25 kg/m2 were reclassified as nonobese after applying the Lancet Commission’s definition of obesity. Individuals with clinical obesity had the highest risk of adverse cardiovascular-kidney-metabolic (CKM) outcomes, while those reclassified as nonobese had an intermediate risk.
CKM outcomes in HK after reclassifying obesity by the Lancet Commission’s definition
27 Mar 2026
Pre-TURBT mitomycin-C improves RFS in NMIBC
In the updated 5-year analysis of a randomized phase II trial, administering two doses of intravesical mitomycin-C (MMC) immediately before transurethral resection of bladder tumour (TURBT) improves recurrence-free survival (RFS) in individuals with non-muscle invasive bladder cancer (NMIBC).
Pre-TURBT mitomycin-C improves RFS in NMIBC
26 Mar 2026
Albuminuria an important fracture risk predictor in T2D
Albuminuria is an important and independent predictor of hip fractures and major osteoporotic fractures (MOF) in patients with type 2 diabetes (T2D), and the presence of additional metabolic syndrome (MetS)–related traits compounds this fracture risk, particularly in nonobese patients, a population-based retrospective cohort study in Hong Kong has shown.